Andres Ruiz Briseno - 14 Dec 2023 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Signature
/s/ Jason Throne, as Attorney-in-Fact for Andres Ruiz Briseno
Issuer symbol
IDYA
Transactions as of
14 Dec 2023
Net transactions value
-$68,002
Form type
4
Filing time
18 Dec 2023, 17:45:13 UTC
Previous filing
06 Sep 2023
Next filing
17 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDYA Common Stock Sale $56,848 -1,672 -5.1% $34.00 30,859 14 Dec 2023 Direct F1
transaction IDYA Common Stock Sale $11,154 -328 -1.1% $34.00 30,531 14 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023.

Remarks:

Title: SVP, Head of Finance and Investor Relations